ABOS
Price
$1.65
Change
+$0.04 (+2.48%)
Updated
Jan 17 closing price
Capitalization
99.13M
72 days until earnings call
MGTX
Price
$6.27
Change
+$0.34 (+5.73%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
489.24M
53 days until earnings call
Ad is loading...

ABOS vs MGTX

Header iconABOS vs MGTX Comparison
Open Charts ABOS vs MGTXBanner chart's image
Acumen Pharmaceuticals
Price$1.65
Change+$0.04 (+2.48%)
Volume$547.08K
Capitalization99.13M
MeiraGTx Holdings
Price$6.27
Change+$0.34 (+5.73%)
Volume$7.29K
Capitalization489.24M
ABOS vs MGTX Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. MGTX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and MGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (ABOS: $1.61 vs. MGTX: $5.93)
Brand notoriety: ABOS and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 93% vs. MGTX: 104%
Market capitalization -- ABOS: $99.13M vs. MGTX: $489.24M
ABOS [@Biotechnology] is valued at $99.13M. MGTX’s [@Biotechnology] market capitalization is $489.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than MGTX.

Price Growth

ABOS (@Biotechnology) experienced а -5.29% price change this week, while MGTX (@Biotechnology) price change was -6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

ABOS is expected to report earnings on May 20, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($489M) has a higher market cap than ABOS($99.1M). MGTX YTD gains are higher at: -2.627 vs. ABOS (-6.395). MGTX has higher annual earnings (EBITDA): -61.2M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. MGTX (123M). ABOS has less debt than MGTX: ABOS (28.5M) vs MGTX (86.7M). MGTX has higher revenues than ABOS: MGTX (13.9M) vs ABOS (0).
ABOSMGTXABOS / MGTX
Capitalization99.1M489M20%
EBITDA-77.89M-61.2M127%
Gain YTD-6.395-2.627243%
P/E RatioN/AN/A-
Revenue013.9M-
Total Cash200M123M163%
Total Debt28.5M86.7M33%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSMGTX
RSI
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with MGTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-5.85%
MGTX - ABOS
49%
Loosely correlated
+3.85%
AURA - ABOS
48%
Loosely correlated
-0.78%
GBIO - ABOS
48%
Loosely correlated
+6.57%
ABCL - ABOS
47%
Loosely correlated
-0.68%
BEAM - ABOS
46%
Loosely correlated
+0.04%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+3.85%
BEAM - MGTX
54%
Loosely correlated
+0.04%
NTLA - MGTX
54%
Loosely correlated
-2.99%
ABOS - MGTX
51%
Loosely correlated
-5.85%
AURA - MGTX
50%
Loosely correlated
-0.78%
EDIT - MGTX
50%
Loosely correlated
+1.64%
More